Dianthus therapeutics to participate in the bank of america securities 2024 health care conference

New york and waltham, mass., may 08, 2024 (globe newswire) -- dianthus therapeutics, inc. (nasdaq: dnth), a clinical-stage biotechnology company dedicated to advancing the next generation of antibody complement therapeutics to treat severe autoimmune diseases, today announced its participation in the bank of america securities 2024 health care conference. marino garcia, chief executive officer, will present a corporate overview on tuesday, may 14, 2024 at 4:20 p.m. pt in las vegas.
DNTH Ratings Summary
DNTH Quant Ranking